The Trial of SHR6508 in Secondary Hyperparathyroidism

Clinical trial NCT06434961 · COMPLETED

Trial details

NCT number: NCT06434961
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Secondary Hyperparathyroidism

Start date: 2024-06-14
Primary completion: 2025-09-29
Enrollment: 498

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.